202 related articles for article (PubMed ID: 17368082)
21. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
[TBL] [Abstract][Full Text] [Related]
22. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
[TBL] [Abstract][Full Text] [Related]
23. Investigation of the SH3BP2 gene mutation in cherubism.
Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
[TBL] [Abstract][Full Text] [Related]
24. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.
Imai Y; Kanno K; Moriya T; Kayano S; Seino H; Matsubara Y; Yamada A
Cleft Palate Craniofac J; 2003 Nov; 40(6):632-8. PubMed ID: 14577811
[TBL] [Abstract][Full Text] [Related]
25. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
[TBL] [Abstract][Full Text] [Related]
26. [Molecular and Cellular Pathogenesis of Cherubism].
Ueki Y
Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
[TBL] [Abstract][Full Text] [Related]
27. The role of SH3BP2 in the pathophysiology of cherubism.
Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
[TBL] [Abstract][Full Text] [Related]
28. Cherubism. A case report.
Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
[TBL] [Abstract][Full Text] [Related]
29. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
30. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
[TBL] [Abstract][Full Text] [Related]
31. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
Teixeira RC; Horz HP; Damante JH; Garlet GP; Santos CF; Nogueira RL; Cavalcante RB; Conrads G
Int J Oral Maxillofac Surg; 2011 Aug; 40(8):851-5. PubMed ID: 21680150
[TBL] [Abstract][Full Text] [Related]
32. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
Deckert M; Prod'Homme V
Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
[No Abstract] [Full Text] [Related]
33. A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.
Sekerci AE; Balta B; Dundar M; Hu Y; Reichenberger EJ; Etoz OA; Nazlim S; Bayrakdar IS
Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e340-4. PubMed ID: 24608212
[TBL] [Abstract][Full Text] [Related]
34. Cherubism gene Sh3bp2 is important for optimal bone formation, osteoblast differentiation, and function.
Mukherjee PM; Wang CJ; Chen IP; Jafarov T; Olsen BR; Ueki Y; Reichenberger EJ
Am J Orthod Dentofacial Orthop; 2010 Aug; 138(2):140.e1-140.e11; discussion 140-1. PubMed ID: 20691350
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic analysis of patients with cherubism.
Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
[TBL] [Abstract][Full Text] [Related]
36. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
37. Cherubism: best clinical practice.
Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
[TBL] [Abstract][Full Text] [Related]
39. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]